19 June 2013
Keywords: biotransplant, starts, organ, transplant, trials, partner, med-immune
Article | 12 February 1996
BioTransplant and partner Med-Immune have started a Phase I/II trial of
BTI-322, a monoclonal antibody for the treatment and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 February 1996
19 February 1996
18 June 2013
© 2013 thepharmaletter.com